X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1216) 1216
Book Review (156) 156
Conference Proceeding (135) 135
Book / eBook (92) 92
Publication (24) 24
Book Chapter (4) 4
Dissertation (3) 3
Magazine Article (2) 2
Paper (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (775) 775
humans (742) 742
oncology (608) 608
female (439) 439
middle aged (326) 326
adult (308) 308
male (283) 283
aged (213) 213
cancer (187) 187
chemotherapy (154) 154
animals (124) 124
expression (97) 97
breast cancer (93) 93
antineoplastic combined chemotherapy protocols - therapeutic use (90) 90
pharmacology & pharmacy (81) 81
radiology, nuclear medicine & medical imaging (80) 80
therapy (78) 78
apoptosis (73) 73
tumors (73) 73
antineoplastic agents - therapeutic use (66) 66
carcinoma (66) 66
neoplasms - drug therapy (63) 63
prognosis (63) 63
breast neoplasms - drug therapy (61) 61
cisplatin (61) 61
hematology (61) 61
medicine & public health (58) 58
treatment outcome (57) 57
abridged index medicus (55) 55
research (55) 55
mice (54) 54
drug resistance (53) 53
immunohistochemistry (53) 53
ovarian neoplasms - drug therapy (53) 53
tumor cells, cultured (52) 52
adolescent (51) 51
aged, 80 and over (48) 48
antineoplastic agents - pharmacology (47) 47
breast-cancer (47) 47
pet (47) 47
risk factors (47) 47
analysis (45) 45
antineoplastic combined chemotherapy protocols - adverse effects (44) 44
antineoplastic agents - adverse effects (43) 43
care and treatment (43) 43
medicine, general & internal (43) 43
dose-response relationship, drug (42) 42
neoplasm staging (42) 42
ovarian cancer (42) 42
positron-emission-tomography (42) 42
combined modality therapy (41) 41
hematology, oncology and palliative medicine (41) 41
p-glycoprotein (41) 41
cyclophosphamide - administration & dosage (37) 37
gastroenterology & hepatology (37) 37
in-vivo (35) 35
lung neoplasms - drug therapy (35) 35
pharmacokinetics (34) 34
apoptosis - drug effects (33) 33
breast neoplasms - therapy (32) 32
metastasis (32) 32
phase-i (32) 32
radiotherapy (32) 32
cell line, tumor (31) 31
drug administration schedule (31) 31
high-dose chemotherapy (31) 31
multidrug resistance (31) 31
resistance (31) 31
cell biology (30) 30
cell lung-cancer (30) 30
cells (30) 30
cisplatin - pharmacology (30) 30
health aspects (30) 30
survival (30) 30
carboplatin - administration & dosage (29) 29
cyclophosphamide (29) 29
diagnosis (29) 29
medicine (29) 29
physiological aspects (29) 29
breast neoplasms - pathology (28) 28
carboplatin (28) 28
drug therapy (28) 28
endocrinology & metabolism (28) 28
gene (28) 28
neoplasms - metabolism (28) 28
prospective studies (28) 28
proteins (28) 28
trial (28) 28
drug evaluation (27) 27
drug resistance, multiple (27) 27
drug-resistance (27) 27
follow-up studies (27) 27
obstetrics & gynecology (27) 27
pathology (27) 27
surgery (27) 27
time factors (27) 27
quality of life (26) 26
serotonin (26) 26
survival analysis (26) 26
toxicity (26) 26
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (25) 25
Robarts - Stacks (24) 24
Gerstein Science - Stacks (14) 14
Online Resources - Online (4) 4
Pontifical Inst. Mediaeval Studies - Library use only (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
St. Michael's College (John M. Kelly) - 3rd Floor (3) 3
UofT at Mississauga - Stacks (3) 3
Victoria University CRRS - Library use only (3) 3
Victoria University E.J. Pratt - Stacks (3) 3
Art - Library use only (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Pontifical Inst. Mediaeval Studies - Reference (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Earth Sciences (Noranda) - Reference (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Reference (1) 1
OISE - Stacks (1) 1
Physics - Reference (1) 1
Physics - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Guest (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Storage (1) 1
Royal Ontario Museum - Reference Desk (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - Rare Book (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Library use only (1) 1
Victoria University E.J. Pratt - Riese (1) 1
Victoria University E.J. Pratt - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1205) 1205
French (101) 101
Dutch (42) 42
Turkish (19) 19
German (14) 14
Spanish (9) 9
Portuguese (8) 8
Italian (6) 6
Japanese (2) 2
Latin (2) 2
Ancient Greek (1) 1
Middle (1) 1
Romanian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 08/2017, Volume 44, Issue 8, pp. 1328 - 1336
c-MET and its ligand hepatocyte growth factor are often dysregulated in human cancers. Dynamic changes in c-MET expression occur and might predict drug... 
HSP90 | ZR-89-BEVACIZUMAB PET | IMMUNO-PET | HEPATOCYTE GROWTH-FACTOR | DOWN-REGULATION | PHASE-II | KINASE INHIBITORS | HSP90 INHIBITOR NVP-AUY922 | TUMOR XENOGRAFT | CELL LUNG-CANCER | BREAST-CANCER | Erlotinib | c-MET | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Zr-89 | PET | Onartuzumab
Journal Article
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, ISSN 1540-1405, 04/2019, Volume 17, Issue 4, pp. XXI - XXI
Journal Article
Cancer Research, ISSN 0008-5472, 02/2016, Volume 76, Issue 4 Supplement, pp. P6 - P6-08-01
Journal Article
MABS, ISSN 1942-0862, 2017, Volume 9, Issue 8, pp. 1370 - 1378
Treatment of human epidermal growth factor receptor 2 (HER2)-driven breast cancer with tyrosine kinase inhibitor lapatinib can induce a compensatory HER3... 
MEDICINE, RESEARCH & EXPERIMENTAL | TYROSINE KINASE | mAb3481 | lapatinib | breast cancer | BIODISTRIBUTION | molecular imaging | CANCER | resistance | BREAST | ERBB3 | EPIDERMAL-GROWTH-FACTOR | MICE | INHIBITORS | HER2 | UP-REGULATION | EXPRESSION | Zr-89 | PET | HER3
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2014, Volume 50, Issue 16, pp. 2889 - 2891
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2011, Volume 364, Issue 6, pp. 514 - 523
Journal Article
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, ISSN 1570-0232, 09/2000, Volume 747, Issue 1-2, pp. 33 - 48
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 11, pp. 2730 - 2741
PURPOSE: to provide proof of principle of safety, breast tumor-specific uptake and positive tumor margin assessment of the systemically administered... 
ANTIBODIES | INDOCYANINE GREEN | IN-111-BEVACIZUMAB | ANGIOGENESIS | ONCOLOGY | SAFETY | CONSERVING SURGERY | MARGINS | OVARIAN-CANCER | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Optical Imaging | Bevacizumab - adverse effects | Humans | Male | Positron-Emission Tomography | Benzenesulfonates - administration & dosage | Vascular Endothelial Growth Factor A - genetics | Indoles - administration & dosage | Benzenesulfonates - adverse effects | Drug-Related Side Effects and Adverse Reactions - pathology | Feasibility Studies | Antibodies, Monoclonal, Humanized - administration & dosage | Breast Neoplasms, Male - diagnostic imaging | Female | Breast Neoplasms - diagnostic imaging | Antibodies, Monoclonal, Humanized - adverse effects | Breast Neoplasms, Male - diagnosis | Tissue Distribution - drug effects | Bevacizumab - administration & dosage | Breast Neoplasms, Male - drug therapy | Breast Neoplasms - drug therapy | Indoles - adverse effects | Breast Neoplasms - pathology | Cell Line, Tumor | Breast Neoplasms - diagnosis | Breast Neoplasms, Male - pathology | Multiplexing | Drug delivery systems | Intravenous administration | Invasiveness | Feasibility studies | Fluorescence | I.R. radiation | Breast cancer | Patients | Bevacizumab | Surgical instruments | Histopathology | Microscopy | Experimental design | Safety engineering | Surgery | Breast | In vivo methods and tests | Safety | Vascular endothelial growth factor | Cancer | Index Medicus
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 07/2014, Volume 35, Issue 7, pp. 785 - 786
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2016, Volume 34, Issue 32, pp. 3906 - +
Journal Article